Semaglutide Cuts Liver Disease Severity in People With HIV
(MedPage Today) -- DENVER -- Semaglutide (Ozempic) reduced the amount of liver fat by nearly a third in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), the open-label phase IIb SLIM LIVER study showed.
In...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news